Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening.
Damon C, Luck M, Toullec L, Etienne I, Buchler M, Hurault de Ligny B, Choukroun G, Thierry A, Vigneau C, Moulin B, Heng AE, Subra JF, Legendre C, Monnot A, Yartseva A, Bateson M, Laurent-Puig P, Anglicheau D, Beaune P, Loriot MA, Thervet E, Pallet N. Damon C, et al. Among authors: choukroun g. Am J Transplant. 2017 Apr;17(4):1008-1019. doi: 10.1111/ajt.14040. Epub 2016 Oct 7. Am J Transplant. 2017. PMID: 27597269 Free article. Clinical Trial.
A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients.
Jannot AS, Vuillemin X, Etienne I, Buchler M, Hurault de Ligny B, Choukroun G, Colosio C, Thierry A, Vigneau C, Moulin B, Rerolle JP, Heng AE, Subra JF, Legendre C, Beaune P, Loriot MA, Thervet E, Pallet N. Jannot AS, et al. Among authors: choukroun g. Ther Drug Monit. 2016 Apr;38(2):223-9. doi: 10.1097/FTD.0000000000000267. Ther Drug Monit. 2016. PMID: 26829596 Clinical Trial.
Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations.
Pallet N, Jannot AS, El Bahri M, Etienne I, Buchler M, de Ligny BH, Choukroun G, Colosio C, Thierry A, Vigneau C, Moulin B, Le Meur Y, Heng AE, Subra JF, Legendre C, Beaune P, Alberti C, Loriot MA, Thervet E. Pallet N, et al. Among authors: choukroun g. Am J Transplant. 2015 Mar;15(3):800-5. doi: 10.1111/ajt.13059. Epub 2015 Jan 14. Am J Transplant. 2015. PMID: 25588704 Free article.
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype.
Pallet N, Etienne I, Buchler M, Bailly E, Hurault de Ligny B, Choukroun G, Colosio C, Thierry A, Vigneau C, Moulin B, Le Meur Y, Heng AE, Legendre C, Beaune P, Loriot MA, Thervet E. Pallet N, et al. Among authors: choukroun g. Am J Transplant. 2016 Sep;16(9):2670-5. doi: 10.1111/ajt.13788. Epub 2016 Apr 8. Am J Transplant. 2016. PMID: 26990694 Free article.
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study.
Martinez F, Kamar N, Pallet N, Lang P, Durrbach A, Lebranchu Y, Adem A, Barbier S, Cassuto-Viguier E, Glowaki F, Le Meur Y, Rostaing L, Legendre C, Hermine O, Choukroun G; NeoPDGF Study Investigators. Martinez F, et al. Among authors: choukroun g. Am J Transplant. 2010 Jul;10(7):1695-700. doi: 10.1111/j.1600-6143.2010.03142.x. Am J Transplant. 2010. PMID: 20642691 Free article. Clinical Trial.
Optimization of initial tacrolimus dose using pharmacogenetic testing.
Thervet E, Loriot MA, Barbier S, Buchler M, Ficheux M, Choukroun G, Toupance O, Touchard G, Alberti C, Le Pogamp P, Moulin B, Le Meur Y, Heng AE, Subra JF, Beaune P, Legendre C. Thervet E, et al. Among authors: choukroun g. Clin Pharmacol Ther. 2010 Jun;87(6):721-6. doi: 10.1038/clpt.2010.17. Epub 2010 Apr 14. Clin Pharmacol Ther. 2010. PMID: 20393454 Clinical Trial.
Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort.
Cognard N, Anglicheau D, Gatault P, Girerd S, Essig M, Hurault de Ligny B, Le Meur Y, Le Roy F, Garrouste C, Thierry A, Colosio C, Rivalan J, Sayegh J, Choukroun G, Moulin B, Caillard S. Cognard N, et al. Among authors: choukroun g. Transplantation. 2018 May;102(5):860-867. doi: 10.1097/TP.0000000000002009. Transplantation. 2018. PMID: 29215458
Replacement kidney lipomatosis after renal transplantation.
Laouad I, Büchler M, Weestel PF, Lebranchu Y, Legendre C, Choukroun G, Thervet E. Laouad I, et al. Among authors: choukroun g. Transplantation. 2005 Feb 27;79(4):496-8. doi: 10.1097/01.tp.0000151002.36566.0b. Transplantation. 2005. PMID: 15729179
Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity study.
Thierry A, Mourad G, Büchler M, Choukroun G, Toupance O, Kamar N, Villemain F, Le Meur Y, Legendre C, Merville P, Kessler M, Heng AE, Moulin B, Queré S, Di Giambattista F, Lecuyer A, Touchard G. Thierry A, et al. Among authors: choukroun g. J Transplant. 2014;2014:171898. doi: 10.1155/2014/171898. Epub 2014 Mar 5. J Transplant. 2014. PMID: 24829794 Free PMC article.
326 results